From: Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma
M | M/U | U | Ratio | P-value | ||
---|---|---|---|---|---|---|
miR-9-1 a | sensitive | 5 | 17 | 0 | 18.18 % | |
resistant | 1 | 43 | 0 | 2.27 % | 0.006 | |
miR-9-2 b | sensitive | 0 | 13 | 9 | 59.09 % | |
resistant | 0 | 17 | 27 | 38.64 % | 0.116 | |
miR-9-3 b | sensitive | 0 | 17 | 5 | 77.27 % | |
resistant | 0 | 21 | 23 | 47.73 % | 0.022 |